Home / What we do

At Laurus Labs, we are driven by an ambitious vision to secure market leadership in our core focus areas.

Laurus Labs aspires to become a most-admired pharmaceutical and biotechnology company with a clear focus on four growing areas: APIs, FDFs, synthesis and biotechnology. Our early investments in R&D and manufacturing have enabled us to become a leading manufacturer of Active Pharmaceutical Ingredients (APIs) for anti-retroviral (ARV) and Hepatitis C drugs. We also manufacture APIs for Oncology and other therapeutic areas.

With world-class manufacturing facilities capable of large-scale commercial API production, we are positioned as suppliers of choice for pharmaceutical companies seeking to leverage our technical expertise and cost-effective manufacturing capabilities. Our facilities have received approvals from WHO, USFDA, NIP Hungary, PMDA, KFDA and BfArM. Our state-of-the-art Fixed Dosage Formulations (FDF) manufacturing facility has a capacity of one billion tablets per year, which can be expanded to 5 billion tables per year.

Our Synthesis business leverages our strong process chemistry skills to provide analytical and research services, clinical research supplies, and commercial-scale contract manufacturing services for global pharmaceutical companies. We also develop and manufacture speciality ingredients for use in nutraceuticals, dietary supplements and cosmeceutical products.